Due to stabilizing effect on the DMPK locus in somatic cells, repeat interruptions predispose DM1 patients to develop disease later than average, supporting the assumption that they can act as genetic modifier of DM1 phenotype. This evidence concerns the gene DMPK and myotonic dystrophy type 1.